Home  »  Markets   »  Why should you keep an eye on Imago BioSciences In...

Why should you keep an eye on Imago BioSciences Inc. (IMGO)?

Imago BioSciences Inc. (NASDAQ: IMGO) is 50.15% higher on its value in year-to-date trading and has touched a low of $11.56 and a high of $35.75 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The IMGO stock was last observed hovering at around $35.59 in the last trading session, with the day’s gains setting it 0.01% off its average median price target of $36.00 for the next 12 months. It is also 1.11% off the consensus price target high of $36.00 offered by 6 analysts, but current levels are -1.71% lower than the price target low of $35.00 for the same period.

Currently trading at $35.60, the stock is 99.05% and 115.72% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.87 million and changing 0.03% at the moment leaves the stock 106.32% off its SMA200. IMGO registered 52.59% gain for a year compared to 6-month gain of 135.14%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The stock witnessed a 124.89% loss in the last 1 month and extending the period to 3 months gives it a 111.65%, and is 97.78% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.29% over the week and 6.68% over the month.

Distance from 52-week low is 207.96% and -0.42% from its 52-week high.

Imago BioSciences Inc. (IMGO) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Imago BioSciences Inc. (IMGO) is a “Hold”. 6 analysts offering their recommendations for the stock have an average rating of 1.30, where 5 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Imago BioSciences Inc. is expected to release its quarterly report on 03/23/2023.The EPS is expected to shrink by -116.80% this year.

Imago BioSciences Inc. (IMGO) Top Institutional Holders

The shares outstanding are 33.77M, and float is at 31.70M with Short Float at 11.17%.

Imago BioSciences Inc. (IMGO) Insider Activity

A total of 19 insider transactions have happened at Imago BioSciences Inc. (IMGO) in the last six months, with sales accounting for 9 and purchases happening 10 times. The most recent transaction is an insider sale by Eichorn Laura G.,the company’sChief Financial Officer. SEC filings show that Eichorn Laura G. sold 553 shares of the company’s common stock on Nov 02 at a price of $18.00 per share for a total of $9954.0. Following the sale, the insider now owns 0.21 million shares.

Imago BioSciences Inc. disclosed in a document filed with the SEC on Nov 02 that Tapper Amy E.sold a total of 750 shares of the company’s common stock. The trade occurred on Nov 02 and was made at $17.90 per share for $13425.0. Following the transaction, the insider now directly holds 0.12 million shares of the IMGO stock.

Still, SEC filings show that on Aug 22, Eichorn Laura G. (Chief Financial Officer) disposed off 447 shares at an average price of $18.00 for $8046.0. The insider now directly holds 207,737 shares of Imago BioSciences Inc. (IMGO).

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.